US Stock MarketDetailed Quotes

LYRA Lyra Therapeutics

Watchlist
  • 0.180
  • +0.010+5.88%
Close Dec 20 16:00 ET
  • 0.183
  • +0.003+1.67%
Post 20:01 ET
11.78MMarket Cap-0.12P/E (TTM)

About Lyra Therapeutics Company

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.

Company Profile

SymbolLYRA
Company NameLyra Therapeutics
Listing DateMay 1, 2020
Issue Price16.00
Founded2005
CEODr. Maria Palasis, PhD
MarketNASDAQ
Employees145
Fiscal Year Ends12-31
Address480 Arsenal Way
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-393-4600
Websitehttp://www.lyratherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Maria Palasis, PhD
  • Director, President and Chief Executive Officer
  • 1.79M
  • Dr. Richard Nieman
  • Chief Medical Officer
  • --
  • Jason Cavalier
  • Chief Financial Officer, Treasurer and Principal Accounting Officer
  • --
  • Dr. Harlan W. Waksal,M.D.
  • Executive Chairman of the Board
  • 625.06K
  • W. Bradford Smith
  • Independent Director
  • 123.81K
  • Dr. Nancy L. Snyderman, F.A.C.S.,M.D.
  • Independent Director
  • 109.06K
  • James R. Tobin
  • Lead Independent Director
  • 152.31K
  • C. Ann Merrifield
  • Independent Director
  • 113.06K
Heat List
US
Overall
Symbol
Price
% Chg

No Data